Gagging for it

doi:10.1136/bmj.b4444

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Our online table of contents is updated at least twice each day. Read all articles published in the last 7 days.
Keep up to date with cardiology: Access the latest cardiovascular medicine resources from across BMJ Group.
The BMJ iPad app brings you the best of print and online, including live links to the latest news, blogs, video, and podcasts. Get the BMJ iPad app.
OPEN ACCESS: All research articles are freely available online, with no word limit. Find out more about the BMJ's open access policy. Submit your paper.
Countdown to London 2012: BMJ Group's Olympics portal highlights latest Olympics and sports medicine-themed research, comment and learning

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Tony Delamothe, deputy editor, BMJ

tdelamothe{at}bmj.com

First, the good news on transparency. Drug company Merck is following Eli Lilly’s lead by publishing details of fees paid to experts for speaking on behalf of the company or its products (doi:10.1136/bmj.b4409). GlaxoSmithKline and Pfizer have promised to follow suit. If drug companies were also to publish details of grants made to patient groups, along with the raw data from their research studies, then truly we would have entered a golden age.

The bad news on transparency is that certain NHS trusts’ idea of a golden age is one where tongues can be ripped out and mouths stitched up. Jonathan Gornall documents the …